Trials / Terminated
TerminatedNCT00870441
Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers
A Phase 1, Randomized, Double-Blind, Multiple Dose, Multi-Center Study to Compare the Safety of ASP2151 to Valacylcovir and Placebo in Healthy Male and Female Subjects
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 442 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to compare the safety of ASP2151 to valacyclovir and placebo in healthy male and female adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP2151 | Oral |
| DRUG | Valacyclovir | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-03-27
- Last updated
- 2013-02-28
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00870441. Inclusion in this directory is not an endorsement.